Showing results (61-70 of 290) with videos related to
Sort By:
Pageof 29
Cancer|February 10, 2010
The effect of changes in Medicare reimbursement on the practice of office and hospital-based endoscopic surgery for bladder cancerMicah L Hemani, Danil V Makarov, William C Huang, et al.Reviews in Urology|April 25, 2009
Renal involvement by chronic myelomonocytic leukemia requiring nephroureterectomyElias S Hyams, Raavi Gupta, Jonathan Melamed, et al.Urology|October 31, 2006
Impact of discordant radiologic and pathologic tumor size on renal cancer stagingJamie A Kanofsky, Courtney K Phillips, Michael D Stifelman, et al.Journal of Magnetic Resonance Imaging : JMRI|June 14, 2014
Pilot study of a novel tool for input-free automated identification of transition zone prostate tumors using T2- and diffusion-weighted signal and textural featuresJoseph N Stember, Fang-Ming Deng, Samir S Taneja, et al.BJU International|February 5, 2009
Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer?Basir Tareen, Guilherme Godoy, Alex Sankin, et al.Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 19, 2023
A prospective study of cancer detection rates following early repeat imaging and biopsy of PI-RADS 4 and 5 regions of interest exhibiting no clinically significant prostate cancer on prior biopsyEzequiel Becher, James S Wysock, Samir S Taneja, et al.Urology|April 4, 2008
Granular cell tumor of scrotum: a rare tumor of the male external genitaliaGuilherme Godoy, Patrick W Mufarrij, Hui C Tsou, et al.Urology|November 29, 2008
Appropriate candidates for hemiablative focal therapy are infrequently encountered among men selected for radical prostatectomy in contemporary cohortBasir Tareen, Alex Sankin, Guilherme Godoy, et al.Primary Care|August 14, 2010
Prostate-specific antigen testing and prostate cancer screeningBob Djavan, Elisabeth Eckersberger, Julia Finkelstein, et al.The Journal of Urology|January 20, 2009
Laterality alone should not drive selection of candidates for hemi-ablative focal therapyBasir Tareen, Guilherme Godoy, Alex Sankin, et al.Pageof 29